SALICYLIC ACID- liquid wart remover liquid 
Dolgencorp, Inc. (DOLLAR GENERAL & REXALL)

----------

Dollar General - Rexall - Liquid Wart Remover

Active ingredient

Salicylic acid 17%w/w

Purpose

Wart Remover

Uses

Warnings

For external use only.

Flammable

  • keep away from fire or flame
  • cap bottle tightly and store at room temerature away from heat

Do not use

  • if you are a diabetic or have poor blood circulation, except under the advice and supervision of a doctor or podiatrist
  • on genital warts and warts on the face
  • on moles, birthmarks and warts with hair growing from them
  • on mucous membranes
  • on irritated, infected or reddened skin

When using this product

  • avoid contact with eyes. If product gets into the eyes, flush with water for 15 minutes
  • avoid inhaling vapors

Stop use and ask doctor if

discomfort persists.

Keep out of reach of children.

if swallowed, get medical help or contact a Poison Control Center right away.

Directions

Other information

store between 20° to 30°C (68° to 86°F)

Inactive ingredients

camphor, castor oil, ethanol, ethyl ether, nitrocellulose

Questions?

Call 1-866-964-0939

Principal Display Panel

Rexall

Miximum Strength

Wart Remover Liquid

with Salicylic Acid 17%

NET 0.31 FL. OZ. (9 mL)

Dollar General - Rexall - Liquid Wart Remover

SALICYLIC ACID 
liquid wart remover liquid
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:55910-404
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
SALICYLIC ACID (UNII: O414PZ4LPZ) (SALICYLIC ACID - UNII:O414PZ4LPZ) SALICYLIC ACID0.17 g  in 9 mL
Inactive Ingredients
Ingredient NameStrength
CAMPHOR (NATURAL) (UNII: N20HL7Q941)  
CASTOR OIL (UNII: D5340Y2I9G)  
PYROXYLIN (UNII: KYR8BR2X6O)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:55910-404-319 mL in 1 BOTTLE, WITH APPLICATOR; Type 0: Not a Combination Product06/29/2015
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC Monograph DrugM02806/29/2015
Labeler - Dolgencorp, Inc. (DOLLAR GENERAL & REXALL) (068331990)

Revised: 1/2024
Document Id: 0fb8f809-4477-2fc8-e063-6294a90acbb5
Set id: 3dd7f722-f1b9-4b25-b90d-59eeca750bcf
Version: 6
Effective Time: 20240124
 
Dolgencorp, Inc. (DOLLAR GENERAL & REXALL)